Abstract

Cyclophosphamide 2-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2006 - Veterinary Compounding

Page(s): 454

Download in electronic PDF format for $75
  • Cyclophosphamide 2-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Cyclophosphamide 2-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • cyclophosphamide
  • chemotherapy agents
  • antineoplastic agent
  • immunosuppressant
  • immunosuppressive
  • liquid preparations

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • ALLERGY/IMMUNOLOGY/INFLAMMATION
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 454
Cyclophosphamide 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2010
Pg. 245
Cyclophosphamide 10-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 45
Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Nov/Dec 2019
Pg. 504-510
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
May/Jun 2005
Pg. 234
Piroxicam 2-mg/mL Oral Liquid, Veterinary
Author(s): Allen Loyd V Jr
Jul/Aug 2001
Pg. 268-271
Antineoplastic Agents
Author(s): Ashworth Lisa D
Nov/Dec 2005
Pg. 437-442
Pediatric Oral Liquid Preparations
Author(s): Fonseca Simonne C, Ferreira Anderson de O
May/Jun 2007
Pg. 259-261
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Author(s): Gupta Vishnu D
Jan/Feb 2003
Pg. 10-15
View Sample
Compounding for the Effects of Weapons of Mass Destruction
Author(s): Sammarco Domenic A
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 295
Brompheniramine Maleate 2-mg/5-mL Oral Liquid
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 458
Indomethacin 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2007
Pg. 155
Busulfan 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Sep/Oct 2011
Pg. 435-437
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations
Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
Nov/Dec 2005
Pg. 478
Pyrazinamide 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2006
Pg. 300
Dapsone 2-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2016
Pg. 167-174
Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions
Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA